Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomastosis by liposomal daunorubicin treatment

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report the first case of an HIV negative patient with gastric Kaposi's sarcoma (KS) and peritoneal carcinomatosis in whom a complete response (CR) was obtained after liposomal daunorubicin administration. The patient presented with epigastric pain and hematemesis. Upper gastric endoscopy with multiple biopsies showed gastric involvement by KS. The whole physical examination and the thoraco-abdomino-pelvic CT scans showed no other localization. A total gastrectomy was performed. Histological examination confirmed the diagnosis of KS with involvement of regional lymph nodes and peritoneal lesions. Six cycles of liposomal daunorubicin were given. Post-treatment coelioscopic control was normal. The patient received another six adjuvant cycles of liposomal daunorubicin. The patient is in complete remission six months after the end of treatment. Liposomal daunorubicin is a promising treatment in the non HIV patient with visceral KS.

Cite

CITATION STYLE

APA

Fléchon, A., Lombard-Bohas, C., Boulez, J., Blay, J. Y., & Scoazec, J. Y. (2001). Complete response of an HIV negative gastric Kaposi’s sarcoma (KS) patient with peritoneal carcinomastosis by liposomal daunorubicin treatment. Annals of Oncology, 12(2), 275–276. https://doi.org/10.1023/A:1008314207988

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free